Why I’m excited about Aducanumab (Aduhelm)!
Dr. Nate Bergman quickly summarizes the story up the FDA’s recent “accelerated approval” of Biogen’s – Aducanumab (brand named, Aduhelm). He ends off with surprise about why he is excited about the approval…and it’s probably not what you think! A quick, but useful listen.
In this Episode You Will Learn:
- The terms of the approval of the drug
- What Aducanumab was able to accomplish in Alzheimer’s patients
- The circumstances that led to Aducanumab being approved
- Some of the problems that arise with Aducanumab
- Why I am excited about Aducanumab